RDY logo

RDY
Dr. Reddy's Laboratories Ltd.

614
Mkt Cap
$11.45B
Volume
4.05M
52W High
$16.17
52W Low
$12.26
PE Ratio
17.65
RDY Fundamentals
Price
$13.76
Prev Close
$14.14
Open
$14.11
50D MA
$13.97
Beta
0.38
Avg. Volume
2.04M
EPS (Annual)
$0.8029
P/B
2.77
Rev/Employee
$138,447.28
$10,916.67
Loading...
Loading...
News
all
press releases
JPMorgan Chase & Co. Buys 116,924 Shares of Dr. Reddy's Laboratories Ltd $RDY
JPMorgan Chase & Co. boosted its stake in Dr. Reddy's Laboratories Ltd (NYSE:RDY - Free Report) by 2.0% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,027,710 shares of the company's sto...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
ESPR's Q4 Earnings Lag Estimates, Revenues Beat, Stock Down
Esperion Therapeutics' Q4 revenues surge 144% to $168.4M but EPS of 22 cents misses estimates. Shares fall as mixed results weigh on sentiment.
Zacks·12d ago
News Placeholder
American Century Companies Inc. Acquires 144,530 Shares of Dr. Reddy's Laboratories Ltd $RDY
American Century Companies Inc. grew its holdings in Dr. Reddy's Laboratories Ltd (NYSE:RDY - Free Report) by 13.8% in the 3rd quarter, according to the company in its most recent 13F filing with the...
MarketBeat·12d ago
News Placeholder
Grantham Mayo Van Otterloo & Co. LLC Grows Holdings in Dr. Reddy's Laboratories Ltd $RDY
Grantham Mayo Van Otterloo & Co. LLC raised its holdings in shares of Dr. Reddy's Laboratories Ltd (NYSE:RDY - Free Report) by 82.1% in the 3rd quarter, according to the company in its most recent...
MarketBeat·13d ago
News Placeholder
340,497 Shares in Dr. Reddy's Laboratories Ltd $RDY Purchased by Pinpoint Asset Management Singapore Pte. Ltd.
Pinpoint Asset Management Singapore Pte. Ltd. purchased a new stake in shares of Dr. Reddy's Laboratories Ltd (NYSE:RDY - Free Report) in the third quarter, according to its most recent Form 13F...
MarketBeat·14d ago
News Placeholder
Vanguard Group Inc. Has $71.63 Million Stock Position in Dr. Reddy's Laboratories Ltd $RDY
Vanguard Group Inc. grew its holdings in shares of Dr. Reddy's Laboratories Ltd (NYSE:RDY - Free Report) by 3.0% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund...
MarketBeat·16d ago
News Placeholder
Zacks Industry Outlook Highlights Teva Pharmaceuticals, Sandoz and Dr. Reddy's
TEVA, Sandoz and Dr. Reddy's are shifting toward complex generics and biosimilars to counter pricing pressure and strengthen margins in the competitive generics market.
Zacks·18d ago
News Placeholder
3 Generic Drug Stocks to Watch Despite Industry Headwinds
Generic drugmakers face pricing pressure, but companies like TEVA, SDZNY and RDY are betting on complex generics and biosimilars to protect growth.
Zacks·19d ago
News Placeholder
Fisher Asset Management LLC Decreases Stock Holdings in Dr. Reddy's Laboratories Ltd $RDY
Fisher Asset Management LLC lowered its stake in Dr. Reddy's Laboratories Ltd (NYSE:RDY - Free Report) by 16.7% during the 3rd quarter, according to its most recent disclosure with the Securities and...
MarketBeat·19d ago
News Placeholder
Dr. Reddy's Laboratories Ltd $RDY Shares Sold by Rhumbline Advisers
Rhumbline Advisers lowered its stake in Dr. Reddy's Laboratories Ltd (NYSE:RDY - Free Report) by 24.4% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 277,934...
MarketBeat·26d ago
<
1
2
...
>

Latest RDY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.